Codexis Stock Analysis, Valuation (NASDAQ:CDXS)
Codexis Stock Analysis
Take a look at Amigobulls Codexis stock analysis video. This is our analyst opinion covering the buy and sell arguments for CDXS stock.
Note: Amigobulls stock rating is our opinion based on the historical performance of the company's fundamentals. It is not indicative of the future performance of the stock.
Codexis, Inc. Stock Rating 1.5/5
Amigobulls CDXS stock analysis relies on business fundamentals such as Codexis revenue growth, profits and return on equity measures from the latest quarter 2017 Q3 earnings. Codexis valuation forms a crucial part of our stock analysis. Based on a company's historical fundamentals we arrive at Codexis stock rating which is indicative of the company's financial performance.
Should you sell CDXS stock?
- Codexis revenue saw a decline of -32.9% YoY in 2017 Q3.
- Revenue declined at a CAGR of -19.6% over the last 5 years.
- Over the last twelve months, Codexis posted an average operating loss margin of -75.9%.
- Codexis posted an average Net loss of -76.4% in the last twelve months.
- The lack of profits renders the PE ratio useless for CDXS stock.
- The company is trading at a price to sales multiple of 11.4, which is overvalued in comparison to the Industrial Services industry average multiple of 1.5.
- Codexis has a negative ROIC (Return on Invested Capital) of -454.9%.
- Codexis has a negative return on equity of -137.5%. This indicates that the firm is inefficient at generating profits.
- The company has a negative free cash flow margin of -48.8%.
Codexis Related Company Stock Videos
Investors can make use of the Amigobulls Codexis stock analysis to ascertain how CDXS stock fares in fundamental analysis investment criteria. Fundamentals of a company give detailed information which helps in making invesment decisions.
Codexis revenue growth and profit or net income are the main underlying forces which could detremine the direction of the share price. One can also combine technical analysis and fundamental analysis to get a holistic picture about CDXS stock.